Tiny Gem

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 7.2 MW Glor Rd Community Solar Project in Upstate New York

  • SolarBank plans to develop a 7.2 MW DC ground-mount solar project in upstate New York, part of a growing pipeline of SolarBank developments in the area.
  • The project will operate under a community solar model, with customer acquisition managed by Solar Simplified, and is expected to power approximately 850 homes.
  • In addition, the new development will participate in New York’s VDER rate program and may qualify for NYSERDA incentives.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., announced the development of a new 7.2 megawatt DC ground-mount solar project in upstate New York. The Glor Rd project, as it is known, adds to a string of solar installations that the company is developing across the region (https://ibn.fm/Z98Pf).

The project will operate under New York’s community solar framework, which allows residents and renters to subscribe to clean energy without installing solar panels on their own properties. Once online, the project is expected to provide electricity for approximately 850 homes.

The company has secured a lease for the project site and initiated its interconnection study, a key step in assessing how the project will connect to the local electric grid. Completion of the study will allow the company to move forward with permitting and financing.

The project is eligible for compensation under New York’s Value of Distributed Energy Resources (“VDER”) mechanism. The VDER rate compensates solar projects for the energy they supply to the grid. For Glor Rd, the projected average year-one compensation is $0.0971/kWh under Public Utility Commission case 15-E-0751.

In addition, SolarBank is targeting one-time incentives of up to $0.245 per watt DC through the NYSERDA NY-Sun Program. These state-level incentives are designed to support the upfront financing of solar projects and are a key part of New York’s broader renewable energy strategy.

Once operational, Glor Rd will feed power directly into the grid, with subscribed residents earning monthly credits on their electric bills. Solar Simplified, SolarBank’s customer acquisition and subscription partner, will handle outreach, enrollment, and ongoing subscriber management. This arrangement enables SolarBank to concentrate on project development while ensuring a reliable revenue stream from full project subscription.

The Glor Rd site is part of a broader expansion by SolarBank across upstate New York, where the company is developing a pipeline of solar assets totaling more than one gigawatt. This effort reflects both state policy momentum in support of clean energy and growing private-sector appetite for distributed solar generation.

The project announcement reinforces SolarBank’s activity in a state that has been aggressively pursuing renewable energy targets. With policies like VDER and NYSERDA incentives in place, upstate New York continues to offer fertile ground for clean energy developers seeking stable returns and long-term growth.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward-looking information. Please refer to the press release entitled “7.2 MW Glor Rd Solar Project in Development by SolarBank in New York” for additional details on the statements, assumptions and risks.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office

TinyGems is powered by IBN

Christian Amiscua

Share
Published by
Christian Amiscua

Recent Posts

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape

Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…

3 days ago

Scientists Discover Why Colon Cancer Diagnoses are Increasing in Young Adults

Researchers have found that people under 50 who develop colorectal cancer have unusually rigid colon tissue that helps tumors…

5 days ago

US Military Admits it is Using AI in Attacks Against Iran

The U.S. military has confirmed that AI systems are actively involved in its ongoing operations against Iran, an admission that…

7 days ago

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

7 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships

LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and…

1 week ago

Researchers Trace Differing Pediatric Brain Tumors to Common Source

New research has uncovered a shared biological weakness running across three distinct pediatric brain cancers, a finding…

2 weeks ago